Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 50,000 shares at $73.22 ($3.6M) on 2019-08-01, disclosed to the SEC on 2019-08-05.
Scheduled sale ($3.6M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.72 | 17,628 | $1.3M | 35.3% |
| 2 | $73.22 | 7,372 | $540K | 14.9% |
| 3 | $72.43 | 25,000 | $1.8M | 49.8% |
| Total | $72.65 avg | 50,000 | $3.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |
| GHDX | SELL | 2019-06-13 | $5.1M | — | Filing → |